A contemporary review of multiple organ failure

Middle East Journal of Anesthesiology

Volumn 18, Issue 2, 2005, Pages 273-292

  Kaye, Alan D ^a   Hoover, Jason M ^a   Baluch, Amir R ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; HUMAN; MULTIPLE ORGAN FAILURE; REVIEW;

DISEASE PROGRESSION; HUMANS; MULTIPLE ORGAN FAILURE;

EID: 22544487215     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. rd ed. Philadelphia, PA: Lippincott-Raven Publishers; 343-358, 1997.
2. BAUE AE, DURHAM R, FAIST E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock; 10(2):79-89, 1998.
3. BARTELS H, ZANT N, HOLZMANN B, ET AL: Special therapeutic approaches for interrupting the cascade-from systemic inflammatory response syndrome to multiple organ failure. Langenbecks Arch Chir Suppl Kongressbd; 115:615-618, 1998.
4. RENSING H, BAUER M: Multiple organ failure. Mechanisms, clinical manifestations and treatment strategies. Anaesthesist; 50(11):819-841, 2001.
5. HSU HH, CHANG CT, LIN JL: Intravenous paraquat poisoning-induced multiple organ failure and fatality-a report of two cases. J Toxicol Clin Toxicol; 41(1):87-90, 2003.
6. LANG C, BEHNKE H, BITTERSOHL J, ET AL: Special features of intensive care of toxic shock syndrome. Review and case report of a TSST-1 associated toxic-shock syndrome with adult respiratory distress syndrome and multiple organ failure from a staphylococcal panaritium. Anaesthesist; 52(9):805-813, 2003.
7. SCHUMMER W, SCHUMMER C: Two cases of delayed diagnosis of postpartal streptococcal toxic shock syndrome. Infections Diseases in Obstetrics and Gynecology; 10(4):217-222, 2002.
8. TOKEL K, VARAN B, SAYGILI A, ET AL: Multiorgan failure due to coarctation of the aorta: management and coutcome of five neonates. Pediatric Emergency Care; 18(4):E8-10, 2002.
9. nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 278-298, 502-512, 1998.
10. HASKO G, DEITCH EA, SZABO C, ET AL: Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr Opin Pharmacol; 2(4):440-444, 2002.
11. OBERHOLZER A, KEEL M, ZELLWEGER R, ET AL: Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma; 48(5):932-937, 2000.
12. BILEVICIUS E, DRAGOSAVAC D, DRAGOSAVAC S, ET AL: Multiple organ failure in septic patients. Braz J Infect Dis; 5(3):103-110, 2001.
13. NAST-KOLB D, AUFMKOLK M, RUCHOLTZ S, ET AL: Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma. J Trauma; 51(5):835-841; discussion 841-842, 2001.
14. SHERIDAN RL, RYAN CM, YIN LM, ET AL: Death in the burn unit: sterile multiple organ failure. Burns; 24(4):307-311, 1998.
15. CALKINS CM, BENSARD DD, MOORE EE, ET AL: The injured child is resistant to multiple organ failure: a different inflammatory response? J Trauma; 53(6): 1058-1063, 2002.
16. SAADIA R, SCHEIN M: Multiple organ failure. How valid is the "two hit" model? J Accid Emerg Med; 16(3): 163-166; discussion 166-167, 1999.
17. ERIUKHIN IA: "Multiple organ failure syndrome." Nature of the concept and correctness of the nomenclature. Vestn Khir Im I I Grek; 159(4): 12-19, 2000.
18. BION JF: Is the gut responsible for multiple organ failure? Schweiz Med Wochenschr; 129(43): 1600-1604, 1999.
19. DIATTA B, PETROGNANI R, ANGEL G, ET AL: Multiple organ failure syndrome after ovarian hyperstimulation. Med Trop (Mars); 57(4):373-374, 1997.
20. FUKUSHIMA R, KOBAYASHI S, OKINAGA K: Bacterial translocation in multiple organ failure. Nippon Geka Gakkai Zasshi; 99(8):497-503, 1998.
21. LEMAIRE LC, VAN LANSCHOT JB, STOUTENBEEK CP, ET AL: Thoracic duct in patients with multiple organ failure: no major route of bacterial translocation. Ann Surg; 229(1):128-136, 1999.
22. DEITCH EA: Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care; 7(2):92-98, 2001.
23. MOOR FA: The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg; 178(6):449-453, 1999.
24. ZALLEN G, OFFNER PJ, MOORE EE, ET AL: Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg; 178(6):570-572, 1999.
25. MOTOYAMA T, OKAMOTO K, KUKITA I, ET AL: Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med; 31(4): 1048-1052, 2003.
26. BOWN MJ, NICHOLSON ML, BELL PR, ET AL: Cytokines and inflammatory pathwas in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Sur; 22(6):485-495, 2001.
27. HAMANO K, GOHRA H, NODA H, ET AL: Increased serum interleukin-8: correlation with poor prognosis in patients with postoperative multiple organ failure. World J Surg; 22(10): 1077-1081, 1998.
28. WHALEN MJ, DOUGHTY LA, CARLOS TM, ET AL: Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med; 28(7):2600-2607, 2000.
29. DOUGHTY L, CARCILLO JA, KAPLAN S, ET AL: The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest; 113(6): 1625-1631, 1998.
30. PARTRICK DA, MOORE EE, SILLIMAN CC, ET AL: Secretory phospholipase A2 activity correlates with postinjury multiple organ failure. Crit Care Med' 29(5):989-993, 2001.
31. RIABOV GA, AZISOV IUM: Role of nitric oxide as a regulator of cell processes in the formation of multiple organ failure. Anesteziol Reanimatol; (1):8-13, 2001.
32. BIFFL WL, MOORE EE, ZALLEN ET AL: Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure. Surgery; 126(2): 189-202, 1999.
33. HASSOUN HT, KONE BC, MERCER DW, ET AL: Post-injury multiple organ failure: the role of the gut. Shock; 15(1):1-10, 2001.
34. ASAKURA H. ONTACHI Y, MIZUTANI T, ET AL: An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med; 29(6): 1164-1168, 2001.
35. UENO H, HIRASAWA H, ODA S, ET AL: Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure. Crit Care Med; 30(10):2242-2248, 2002.
36. YAO YM, REDL H, BAHRAMI S, ET AL: The inflammatory basis of trauma/shock-associated multiple organ failure. Infalmm Res; 47(5):201-210, 1998.
37. SAUAIA A, MOORE FA, MOORE EE, ET AL: Multiple organ failure can be predicted as early as 12 hours after injury. J Trauma; 45(2):291-301; discussion 301-303, 1998.
38. ODA S, HIRASAWA H, SUGAI T, ET AL:Cellular injury score for multiple organ failure severity scoring system. J Trauma; 45(2):304-310; discussion 310-311, 1998.
39. CRYER HG, LEONG K, MCARTHUR DL, ET AL: Multiple organ failure: by the time you predict it, it's already there. J Trauma; 46(4):597-604; discussion 604-606, 1999.
40. BALOGH Z, OFFNER PJ, MOORE EE, ET AL: NISS predicts postinjury multiple organ failure better than the ISS. J Trauma; 48(4):624-627; discussion 627-628, 2000.
41. LIN KJ, KAO MT, LIAO-JEN, ET AL: Comparison of acute physiology and chronic health evalutation III and II for prediction of mortality in multiple organ failure patients treated by plasma exchange. Ther Apher; 1(2):195-198, 1997.
42. SOTNIKOV AV, KURMUKOV IA: Prognostic value of SAPS II and APACHE II scales in patients with multiple organ failure syndrome during early postoperative period after oncological surgery. Anesteziol Reanimatol; (2):37-39, 2003.
43. GROTZ M, VON GRIENSVEN M, STALP M, ET AL: Scoring multiple organ failure after severe trauma. Comparison of the Goris, Marshall and Moore scores. Chirurg; 72(6):723-730, 2001.
44. LEFERING R, GORIS RJ, VAN NIEUWENHOVEN EJ, ET AL: Revision of the multiple organ failure score. Langenbecks Arch Surt; 387(1):14-20, 2002.
45. CHALENKO VV: Classification of acute dysfunctions of organs and systems in multiple organ failure syndrome. Anesteziol Reanimatol; (2):25-30, 1998.
46. SIZOV DN, KOSTIUCHENKO AL, BEL'SKIKH AN: Multiple organ failure syndrome in critically ill patients. Anesteziol Reanimatol; (2):22-25, 1998.
47. STEGMAYR BG, BANGA R, BERGGREN L, ET AL: Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med; 31(6):1730-1736, 2003.
48. BOYD O, BENNETT ED: Enhancement of perioperative tissue perfusion as a therapeutic strategy for major surgery. New Horizons; 4(4):453-465, 1996.
49. ABID O, AKCA S, HAJI-MICHAEL P, ET AL: Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med; 28(4):947-949, 2000.
50. MOLNAR Z, EUAN S: The role of elective hemofiltration in the management of sepsis and multiple organ failure. Orv Hetil; 139(20):1229-1233, 1998.
51. HOFFMAN H, MARKEWITZ A, KREUZER E, ET AL: Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock; 9(4):235-240, 1998.
52. BASTIAN L, WEIMANN A, REGEL G, ET AL: Is modification of systemic inflammatory response syndrome and multiple organ failure by parenteral feeding possible? Langenbecks Arch Chir Suppl Kongressbd; 115:1083-1085; 1998.
53. EATON S: Impaired energy metabolism during neonatal sepsis: the effects of glutamine. Proceedings of the Nutrition Society; 62(3):745-751, 2003.
54. GUO LM, LIU JY, XU DZ, ET AL: Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver International; 23 suppl 3:16-20, 2003.